Fundraising Fox
Neuronetics
NASDAQ: STIMMalvern, US · Delaware corporation · 6 known investors
Find your way into Neuronetics
Sign up to see every warm intro you have to Neuronetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuronetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuronetics manufactures and sells the NeuroStar Advanced Therapy System, a transcranial magnetic stimulation device used in office-based treatment of major depressive disorder and other mental health conditions, along with operating a network of treatment centers that provide both NeuroStar therapy and esketamine treatment to patients.
Founders & leadership
CT
Christopher ThatcherExecutiveChristopher Thatcher is an executive with experience as CEO and divisional president overseeing commercialization of Class I, II, and III medical devices for both public and private companies, with prior roles spanning capital equipment, disposables, and implantables in office and operating room settings across companies ranging from $20M to $425M in annual revenue.
DL
Daniel L. ReuversPresident and Chief Executive Officer
Board
SC
Stephen CampeBoard director
RK
Robert KuhlingBoard director
LR
Liam RatcliffeBoard director
PS
P. Sherrill NeffBoard director
WJ
Wilfred JaegerBoard director
KB
MD
Michael D. DaleBoard director
BF
Brian FarleyBoard director
Investors · 6
1315 Capitallisted by 1315 CapitalPhiladelphia · $5M – $40M
How we know: 1315 Capital's portfolio page · Not right? Tell us
Western Technology Investmentlisted by Western Technology InvestmentPortola Valley
How we know: westerntech.com · Not right? Tell us
Atlas VentureinferredCambridge · $500K – $1Mvia Kevin Bitterman · board
How we know: board seat on SEC Form D · Not right? Tell us
CHV Capitalreported
How we know: the S-1 prospectus · Not right? Tell us
GE VenturesreportedCincinnati
How we know: the S-1 prospectus · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$58.4M disclosed across 3 rounds · 2014–2017
▶$15MraisedJun 2017 · 22 investors · Other Health CareRule 506(b)
▶$15MraisedJun 2017 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cassie HallbergExecutive Officer
- Anthony PuiExecutive Officer
- Christopher ThatcherExecutive Officer, Director
- Greg HarperExecutive Officer
- Brian FarleyDirector
- Stephen CampeDirector
- Peter DonatoExecutive Officer
- Wilfred JaegerDirector
- Ron HuntDirector
- Steve MacKinnonExecutive Officer
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.3MraisedMay 2015 · 23 investors · Other Health CareRule 506(b)
▶$34.3MraisedMay 2015 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark R. BausingerExecutive Officer
- Stephen CampeDirector
- Robert KuhlingDirector
- Liam RatcliffeDirector
- P. Sherrill NeffDirector
- Wilfred JaegerDirector
- Kevin BittermanDirector
- Michael D. DaleDirector
- Brian FarleyDirector
- Christopher ThatcherExecutive Officer, Director
- Offering amount
- $34.3M
- Amount sold
- $34.3M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedDec 2014 · 23 investors · Other Health CareRule 506(b)
▶$9.1MraisedDec 2014 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- P. Sherrill NeffDirector
- Wilfred JaegerDirector
- Michael D. DaleDirector
- Brian FarleyDirector
- Mark R. BausingerExecutive Officer
- Liam RatcliffeDirector
- Robert KuhlingDirector
- Kevin BittermanDirector
- Stephen CampeDirector
- Offering amount
- $15M
- Amount sold
- $9.1M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
BirdEyeBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
LifeStance HealthLifeStance provides mental healthcare services through a network of clinicians and therapists, delivering outpatient psychiatric and behavioral health treatment across the United States. The company serves patients seeking mental health support and works with providers and health systems to expand access to evidence-based care.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
WazeWorld's largest community-based traffic and navigation app.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Tebra Technologies (FKA Kareo)Tebra provides an all-in-one operating system for independent healthcare practices, combining EHR, medical billing, patient payments, and practice management tools. The platform serves independent practices, billing companies, and various medical specialties including family medicine, primary care, pediatrics, mental health, and nurse practitioner practices.
Companies working in the same space as Neuronetics.
Frequently asked questions
- What does Neuronetics do?
- Neuronetics manufactures and sells the NeuroStar Advanced Therapy System, a transcranial magnetic stimulation device used in office-based treatment of major depressive disorder and other mental health conditions, along with operating a network of treatment centers that provide both NeuroStar therapy and esketamine treatment to patients.
- Who are Neuronetics's investors?
- Neuronetics's investors include 1315 Capital, Ascension Ventures, Western Technology Investment, Atlas Venture, CHV Capital, GE Ventures.
- How much funding has Neuronetics raised?
- Neuronetics has disclosed $58.4M raised across 3 rounds.
- Where is Neuronetics headquartered?
- Neuronetics is headquartered in Malvern, US.